Nanoscopy technology can drive biological discovery not just with imagery, but also with meaningful quantitative data.

New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.

Scientists used transcriptomics to analyze the HCPs, especially the problematic ones, in CHO cultures, and looked for an ...

HILIC-MS lets free thiols in mAb processing be localized directly and quantified at domain-specific resolution.

Large datasets can be used by machine learning to make predictions for better choice of culture media conditions.

Researchers have developed a new organoid that mimics the human fetal pancreas, offering a clearer view of its early development.

Delivering biologics via oral administration represents a growing market that is expected to exhibit 35% CAGR from 2023–2028.

Prostate cancer and other cancers characterized by “cold” tumors could become more responsive to checkpoint blockade if UBA1 is inhibited.

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

Kraig Biocraft Laboratories has developed transgenic silkworms to produce spider silk in commercial quantities.

At GEN’s inaugural virtual summit on The State of AI in Drug Discovery, experts evaluated the evolution, opportunities, and ...

Thaysen stepped in to lead Illumina through a tumultuous time, and now—as this GEN interview relates—he is carrying out his near- and long-term plans for the company.